All In Biotech

Drug Trial Radar · NCT05634473

A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test

A Multicenter, Open-label Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test

Last checked: Nov 20, 2026Latest source record: Dec 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

280

Planned (sponsor's estimate)

Start

Dec 2022

Primary completion

Feb 2023

Study completion Jun 2023

Sponsor

Sponsor type
Industry
First posted
Dec 2, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A multicenter, open-label study to evaluate the sensitivity and specificity of inhaled methacholine in bronchial provocation test

Conditions

  • Asthma

Interventions

  • Methacholine ChlorideDrug

    Cholinergic agonists

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity analysisTime frame: On the 1 day of administration
  2. Specificity AnalysisTime frame: On the 1 day of administration
  3. Provocative dose causing a 20% fall (PD20)Time frame: On the 1 day of administration
  4. Adverse eventsTime frame: Base line to 3 days after dosing
  5. heart rate (Vital signs)Time frame: Base line to 3 days after dosing
  6. oxyhemoglobin saturation (Vital signs)Time frame: Base line to 3 days after dosing
  7. Recovery of forced expiratory volume in 1 second (FEV 1)Time frame: Base line to 3 days after dosing

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • The First Hospital of Lanzhou University

    Lanzhou, Gansu, China

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Guangdong Province Hospital of chinese medicine

    Guangzhou, Guangdong, China

  • Liuzhou people's Hospital

    Liuzhou, Guangxi, China

  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • The Affiliated Hospital of Inner Mongolia Medical Univercity

    Hohhot, Inner Mongolia, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Benxi Central Hospital

    Benxi, Liaoning, China

  • Weifang NO.2 People's Hospital

    Weifang, Shandong, China

  • West China Hospital,Sichuan University

    Chengdu, Sichuan, China

  • Zhejiang Provincial Hospital of Chinese Medicine

    Hangzhou, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.